Maravai LifeSciences Aktie News

Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth

Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth

Accelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth

SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies® (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI), is fueling the future of mRNA research — starting with a significant donation to top academic labs across the U.S. and Europe. The donation commemorates the launch of TriLink's first mRNA synthesis kit featuring CleanCap® capping technology, an all-in-one kit with its innovative prod...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Debra Hart - Head, IR Kevin Herde - EVP and CFO Trey Martin - CEO Becky Buzzeo - EVP & CCO Conference Call Participants Conor McNamara - RBC Capital Markets Daniel Arias - Stifel Tejas Savant - Morgan Stanley Matthew Stanton - Jeffries Brandon Coulliard - Wells Fargo ...

SAN DIEGO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2025, together with other business updates.

LOS ANGELES , May 5, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ: MRVI) for violations of the federal securities laws. Shareholders who purchased the Company's securities between August 7, 2024 and February 24, 2025, inclusive (the "Class Period"), are encouraged to contact th...

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2025 financial and operating results after the market close on Monday, May 12, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p....